212
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

Is Recreational Ecstasy (MDMA) Use Associated with Higher Levels of Depressive Symptoms?

Pages 31-39 | Published online: 08 Sep 2011

REFERENCES

  • Al-Musawi and Nu'man , M. 2001 . Psychometric properties of the Beck Depression Inventory-II with university students in Bahrain . Journal of Personality Assessment , 77 ( 3 ) : 568 – 79 .
  • American Psychiatric Association . 1994 . Diagnostic and Statistical Manual of Mental Disorders. , Fourth Ed. Washington, DC : American Psychiatric Association. .
  • Baron , P. and Hanna , J. 1990 . Egocentrism and depressive symptomatology in young adults . Social Behavior and Personality: An International Journal , 18 ( 2 ) : 279 – 85 .
  • Battaglia , G. , Yeh , S. Y. and De Souza , E. B. 1988 . MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons . Pharmacology Biochemistry and Behavior , 29 ( 2 ) : 269 – 74 .
  • Beck , A. T. and Steer , R. A. 1987 . Manual for the Revised Beck Depression Inventory. San Antonio, TX : The Psychological Corporation. .
  • Beck , A. T. , Steer , R. A. and Brown , G. K. 1996 . Beck Depression Inventory-II Manual. San Antonio, TX : The Psychological Corporation. .
  • Beck , A. T. , Steer , R. A. and Garbin , M. G. 1988 . Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation . Clinical Psychology Review , 8 ( 1 ) : 77 – 100 .
  • Beck , A. T. , Ward , C. H. , Mendelson , M. , Mock , J. and Erbaugh , J. 1961 . An inventory for measuring depression . Archives of General Psychiatry , 4 ( 6 ) : 561 – 71 .
  • Bennie , E. H. , Chakravarti , S. K. , Jarman , C. M.B. , Khan , K. , Master , D. , Murray , G. H. , Meya , U. , Soni , D. , Shaw , S. H. and White , A. C. 1988 . A double-blind dose-finding study of rolipram in patients with major depressive disorder . Human Psychopharmacology: Clinical and Experimental , 3 ( 4 ) : 275 – 80 .
  • Buchert , R. , Thomasius , R. , Wilke , F. , Petersen , K. , Nebeling , B. , Obrocki , J. , Schulze , O. , Schmidt , U. and Clausen , M. 2004 . A voxel-based PET investigation of the long-term effects of “ecstasy” consumption on brain serotonin transporters . American Journal of Psychiatry , 161 ( 7 ) : 1181 – 89 .
  • Buchert , R. , Thomasius , R. , Nebeling , B. , Petersen , K. , Obrocki , J. , Jenicke , L. , Wilke , F. , Wartberg , L. , Zapletalova , P. and Clausen , M. 2003 . Long-term effects of “ecstasy” use on serotonin transporters of the brain investigated by PET . Journal of Nuclear Medicine , 44 ( 3 ) : 375 – 84 .
  • Campbell , D. B. 1996 . Extrapolation from animals to man: The integration of pharmacokinetics and pharmacodynamics . Annals of the New York Academy of Sciences , 801 ( 1 ) : 116 – 35 .
  • Cole , J. C. and Sumnall , H. R. 2003 . Altered states: The clinical effects of Ecstasy . Pharmacology & Therapeutics , 98 ( 1 ) : 35 – 58 .
  • Cole , J. C. and Sumnall , H. R. 2002 . The BDI of the beholder . Journal of Psychopharmacology , 16 ( 1 ) : 103
  • Commins , D. L. , Vosmer , G. , Virus , R. M. , Woolverton , W. L. , Schuster , C. R. and Seiden , L. S. 1987 . Biochemical and histological evidence that methylenedioxymethamphetamine (MDMA) is toxic to neurons in the rat brain . Journal of Pharmacology and Experimental Therapeutics , 241 ( 1 ) : 338 – 45 .
  • Daumann , J. , Hensen , G. , Thimm , B. , Rezk , M. , Till , B. and Gouzoulis-Mayfrank , E. 2004 . Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: Further evidence from a combined cross-sectional/longitudinal investigation . Psychopharmacology , 173 ( 4 ) : 398 – 404 .
  • Daumann , J. , Pelz , S. , Becker , S. , Tuchtenhagen , F. and Gouzoulis-Mayfrank , E. 2001 . Psychological profile of abstinent recreational ecstasy (MDMA) users and significance of concomitant cannabis use . Human Psychopharmacology: Clinical and Experimental , 16 ( 8 ) : 627 – 33 .
  • Derogatis , L. R. 1994 . Symptom Checklist-90-R: Administration, Scoring and Procedures Manual. Baltimore, MD : John Hopkins University Press. .
  • Derogatis , L. R. , Rickels , K. and Rock , A. 1976 . The SCL-90 and the MMPI: A step in the validation of a new self-report scale . British Journal of Psychiatry , 128 ( 3 ) : 280 – 89 .
  • Derogatis , L. R. , Lipman , R. S. and Covi , L. 1973 . An outpatient psychiatric rating scale—preliminary report . Psychopharmacology Bulletin , 9 ( 1 ) : 13 – 28 .
  • de Almeida , S. P. and Silva , M. T.A. 2005 . Characteristics of ecstasy users in Sao Paulo, Brazil . Substance Use & Misuse , 40 ( 3 ) : 395 – 404 .
  • de Win , M. M.L. , Reneman , L. , Reitsma , J. B. , den Heeten , G. J. , Booij , J. and van den Brink , W. 2004 . Mood disorders and serotonin transporter density in ecstasy users: The influence of long-term abstention, dose, and gender . Psychopharmacology , 173 ( 4 ) : 376 – 82 .
  • Dobson , K. S. and Breiter , H. J. 1983 . Cognitive assessment of depression: Reliability and validity of three measures . Journal of Abnormal Psychology , 92 ( 1 ) : 107 – 09 .
  • Dozois , D. J.A. 2003 . The psychometric characteristics of the Hamilton Depression Inventory . Journal of Personality Assessment , 80 ( 1 ) : 31 – 40 .
  • Dughiero , G. , Schifano , F. and Forza , G. 2001 . Personality dimensions and psychopathological profiles of Ecstasy users . Human Psychopharmacology: Clinical and Experimental , 16 ( 8 ) : 635 – 39 .
  • Falck , R. S. , Carlson , R. G. , Wang , J. and Siegal , H. A. 2006 . Psychiatric disorders and their correlates among young adult MDMA users in Ohio . Journal of Psychoactive Drugs , 38 ( 1 ) : 19 – 29 .
  • Gamma , A. , Buck , A. , Berthold , T. and Vollenweider , F. X. 2001 . No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2 15O)-positron emission tomography study . Journal of Clinical Psychopharmacology , 21 ( 1 ) : 66 – 71 .
  • Gerra , G. , Zaimovic , A. , Moi , G. , Giusti , F. , Gardini , S. , Delsignore , R. , Laviola , G. , Macchia , T. and Brambilla , F. 2002 . Effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on dopamine system function in humans . Behavioural Brain Research , 134 ( 2 ) : 403 – 410 .
  • Gerra , G. , Zaimovic , A. , Ferri , M. , Zambelli , U. , Timpano , M. , Neri , E. , Marzocchi , G. F. , Delsignore , R. and Brambilla , F. 2000 . Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans . Biological Psychiatry , 47 ( 2 ) : 127 – 36 .
  • Gerra , G. , Zaimovic , A. , Giucastro , G. , Maestri , M. , Monica , C. , Sartori , R. , Caccavari , R. and Delsignore , R. 1998 . Serotonergic function after (+/-)3,4-methylenedioxymethamphetamine (“ecstasy”) in humans . International Clinical Psychopharmacology , 13 ( 1 ) : 1 – 9 .
  • Gotlib , I. H. 1984 . Depression and general psychopathology in university students . Journal of Abnormal Psychology , 93 ( 1 ) : 19 – 30 .
  • Gouzoulis-Mayfrank , E. and Daumann , J. 2006 . The confounding problem of polydrug use in recreational ecstasy/MDMA users: A brief overview . Journal of Psychopharmacology , 20 ( 2 ) : 188 – 93 .
  • Gudelsky , G. A. , Yamamoto , B. K. and Nash , J. F. 1994 . Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor antagonists . European Journal of Pharmacology , 264 ( 3 ) : 325 – 30 .
  • Guillot , C. and Greenway , D. 2006 . Recreational Ecstasy use and depression . Journal of Psychopharmacology , 20 ( 3 ) : 411 – 16 .
  • Halpern , J. H. , Pope , H. G. , Sherwood , A. R. , Barry , S. , Hudson , J. I. and Yougelun-Todd , D. 2004 . Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs . Drug and Alcohol Dependence , 75 ( 2 ) : 135 – 47 .
  • Hamilton , M. 1960 . A rating scale for depression . Journal of Neurology, Neurosurgery & Psychiatry , 23 ( 1 ) : 56 – 62 .
  • Hedlund , J. and Vieweg , B. 1979 . The Hamilton Rating Scale for Depression: A comprehensive review . Journal of Operational Psychiatry , 10 ( 2 ) : 149 – 62 .
  • Hopkins , K. D. , Hopkins , B. R. and Glass , G. V. 1996 . Basic Statistics for the Behavioral Sciences. , Third Ed. Boston : Allyn & Bacon. .
  • Huizink , A. C. , Ferdinand , R. F. , van der Ende , J. and Verhulst , F. C. 2006 . Symptoms of anxiety and depression in childhood and use of MDMA: Prospective, population based study . British Medical Journal , 332 ( 7545 ) : 825 – 28 .
  • Keppel , G. 1991 . Design and analysis: A Researcher's Handbook. , Third Ed. Upper Saddle River, New Jersey : Prentice-Hall. .
  • Lamers , C. T.J. , Bechara , A. , Rizzo , M. and Ramaekers , J. G. 2006 . Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls . Journal of Psychopharmacology , 20 ( 2 ) : 302 – 11 .
  • Leentjens , A. F.G. , Verhey , F. R.J. , Lousberg , R. , Spitsbergen , H. and Wilmink , F. W. 2000 . The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease . International Journal of Geriatric Psychiatry , 15 ( 7 ) : 644 – 49 .
  • Lieb , R. , Schuetz , C. G. , Pfister , H. , von Sydow , K. and Wittchen , H. 2002 . Mental disorders in ecstasy users: A prospective-longitudinal investigation . Drug and Alcohol Dependence , 68 ( 2 ) : 195 – 207 .
  • Lightfoot , S. L. and Oliver , J. M. 1985 . The Beck Inventory: Psychometric properties in university students . Journal of Personality Assessment , 49 ( 4 ) : 434 – 36 .
  • MacInnes , N. , Handley , S. L. and Harding , G. F.A. 2001 . Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms . Journal of Psychopharmacology , 15 ( 3 ) : 181 – 86 .
  • MacInnes , N. , Handley , S. L. and Harding , G. F.A. 2002 . The BDI of the beholder: An eye for experimental design . Journal of Psychopharmacology , 16 ( 3 ) : 273
  • McCann , U. D. , Szabo , Z. , Scheffel , U. , Dannals , R. F. and Ricaurte , G. A. 1998 . Positron emission tomographic evidence of toxic effect of MDMA (“ecstasy”) on brain serotonin neurons in human beings . Lancet , 352 ( 9138 ) : 1433 – 37 .
  • McCann , U. D. , Szabo , Z. , Secklin , E. , Rosenblatt , P. , Mathews , W. B. , Ravert , H. T. , Dannals , R. F. and Ricaurte , G. A. 2005 . Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB . Neuropsychopharmacology , 30 ( 9 ) : 1741 – 50 .
  • McCardle , K. , Luebbers , S. , Carter , J. D. , Croft , R. J. and Stough , C. 2004 . Chronic MDMA (ecstasy) use, cognition and mood . Psychopharmacology , 173 ( 4 ) : 434 – 39 .
  • Milani , R. M. , Parrott , A. C. , Turner , J. J.D. and Fox , H. C. 2004 . Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users . Addictive Behaviors , 29 ( 5 ) : 965 – 71 .
  • Morgan , M. J. , McFie , L. , Reetwood , L. H. and Robinson , J. A. 2002 . Ecstasy (MDMA): Are the psychological problems associated with its use reversed by prolonged abstinence? . Psychopharmacology , 159 ( 3 ) : 294 – 303 .
  • Nash , J. F. , Meltzer , H. Y. and Gudelsky , G. A. 1990 . Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalanine accumulation in the striatum and nucleus accumbens . Journal of Neurochemistry , 54 ( 3 ) : 1062 – 67 .
  • O'Hearn , E. , Battaglia , G. , De Souza , E. B. , Kuhar , M. J. and Molliver , M. E. 1988 . Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: Immunocyto-chemical evidence for neurotoxicity . Journal of Neuroscience , 8 ( 8 ) : 2788 – 2803 .
  • Parrott , A. C. , Sisk , E. and Turner , J. J.D. 2000 . Psychobiological problems in heavy ecstasy (MDMA) polydrug users . Drug and Alcohol Dependence , 60 ( 1 ) : 105 – 10 .
  • Parrott , A. C. , Milani , R. M. , Parmar , R. and Turner , J. J.D. 2001 . Recreational ecstasy/MDMA and other drug users from the UK and Italy: Psychiatric symptoms and psychobiological problems . Psychopharmacology , 159 ( 1 ) : 77 – 82 .
  • Reneman , L. , Booij , J. , de Bruin , K. , Reitsma , J. B. , de Wolff , F. A. , Gunning , W. B. , den Heeten , G. J. and van den Brink , W. 2001a . Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons . Lancet , 358 ( 9296 ) : 1864 – 69 .
  • Reneman , L. , Lavalaye , J. , Schmand , B. , de Wolff , F. A. , van den Brink , W. and den Heeten , G. J. 2001b . Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or ecstasy): Preliminary findings . Archives of General Psychiatry , 58 ( 10 ) : 901 – 06 .
  • Ricaurte , G. A. , Martello , A. L. , Katz , J. L. and Martello , M. B. 1992 . Lasting effects of (+/-)3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: Neurochemical observations . Journal of Pharmacology and Experimental Therapeutics , 261 ( 2 ) : 616 – 22 .
  • Ricaurte , G. A. , DeLanney , L. E. , Irwin , I. and Langston , J. W. 1988 . Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration . Brain Research , 446 ( 1 ) : 165 – 68 .
  • Rizley , R. 1978 . Depression and distortion in the attribution of causality . Journal of Abnormal Psychology , 87 ( 1 ) : 32 – 48 .
  • Robbins , P. R. and Tanck , R. H. 1984 . The Beck Depression Inventory and self-reports of behavior over a ten-day period . Journal of Personality Assessment , 48 ( 1 ) : 42 – 45 .
  • Robinson , L. A. , Berman , J. S. and Neimeyer , R. A. 1990 . Psychotherapy for the treatment of depression: A comprehensive review of controlled outcome research . Psychological Bulletin , 08 ( 1 ) : 30 – 49 .
  • Roiser , J. P. and Sahakian , B. J. 2004 . Relationship between ecstasy use and depression: A study controlling for polydrug use . Psychopharmacology , 173 ( 4 ) : 411 – 17 .
  • Scanzello , C. R. , Hatzidimitriou , G. , Martello , A. L. , Katz , J. L. and Ricaurte , G. A. 1993 . Serotonergic recovery after (+/-)3,4-methylenedioxymethamphetamine injury: Observations in rats . Journal of Pharmacology and Experimental Therapeutics , 264 ( 3 ) : 1484 – 91 .
  • Schmidt , C. J. , Abbate , G. M. , Black , C. K. and Taylor , V. L. 1990 . Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymeth-amphetamine in rats . Journal of Pharmacology and Experimental Therapeutics , 255 ( 2 ) : 478 – 83 .
  • Scholey , A. B. , Parrott , A. C. , Buchanan , T. , Heffernan , T. M. , Ling , J. and Rodgers , J. 2004 . Increased intensity of ecstasy and polydrug usage in the more experienced recreational ecstasy/MDMA users: A WWW study . Addictive Behaviors , 29 ( 4 ) : 743 – 52 .
  • Semple , D. M. , Ebmeier , K. P. , Glabus , M. F. , O'Carroll , R. E. and Johnstone , E. C. 1999 . Reducedin vivo binding to the serotonin transporter in the cerebral cortex of MDMA (ecstasy) users . British Journal of Psychiatry , 175 ( 1 ) : 63 – 69 .
  • Slikker , W. , Ali , S. F. , Scallet , A. C. , Frith , C. H. , Newport , G. D. and Bailey , J. R. 1988 . Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA) . Toxicology and Applied Pharmacology , 94 ( 3 ) : 448 – 57 .
  • Slikker , W. , Holson , R. R. , Ali , S. F. , Kolta , M. G. , Paule , M. G. , Scallet , A. C. , McMillan , D. E. , Bailey , J. R. , Hong , J. S. and Scalzo , F. M. 1989 . Behavioral and neurochemical effects oforally administered MDMA in the rodent and nonhuman primate . Neurotoxicology , 10 ( 3 ) : 529 – 42 .
  • Steer , R. A. and Clark , D. A. 1997 . Psychometric characteristics of the Beck Depression Inventory-II with college students . Measurement and Evaluation in Counseling and Development , 30 ( 3 ) : 128 – 36 .
  • Stone , D. M. , Hanson , G. R. and Gibb , J. W. 1987 . Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats . Neuropharmacology , 26 ( 11 ) : 1657 – 61 .
  • Stone , D. M. , Merchant , K. M. , Hanson , G. R. and Gibb , J. W. 1987 . Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat . Neuropharmacology , 26 ( 12 ) : 1677 – 83 .
  • Storch , E. A. , Roberti , J. W. and Roth , D. A. 2004 . Factor structure, concurrent validity, and internal consistency of the Beck Depression Inventory-Second Edition in a sample of college students . Depression and Anxiety , 19 ( 3 ) : 187 – 89 .
  • Sumnall , H. R. and Cole , J. C. 2005 . Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: A meta-analysis . Journal of Psychopharmacology , 19 ( 1 ) : 84 – 92 .
  • Thomasius , R. , Petersen , K. , Buchert , R. , Andresen , B. , Zapletalova , P. , Wartberg , L. , Nebeling , B. and Schmoldt , A. 2003 . Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users . Psychopharmacology , 167 ( 1 ) : 85 – 96 .
  • Verkes , R. J. , Gijsman , H. J. , Pieters , M. S.M. , Schoemaker , R. C. , de Visser , S. , Kuijpers , M. , Pennings , E. J.M. , de Bruin , D. , Van de Wijngaart , G. , Van Gerven , J. M.A. and Cohen , A. F. 2001 . Cognitive performance and serotonergic function in users of ecstasy . Psychopharmacology , 153 ( 2 ) : 196 – 202 .
  • Whisman , M. A. and Perez , J. E. 2000 . Factor structure of the Beck Depression Inventory-Second Edition (BDI-II) in a student sample . Journal of Clinical Psychology , 56 ( 4 ) : 545 – 51 .
  • Wilson , M. A. , Ricaurte , G. A. and Molliver , M. E. 1989 . Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methylenedioxymethamphetamine . Neuroscience , 28 ( 1 ) : 121 – 37 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.